Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) (“OncBioMune” or the “Company”), a clinical-stage biopharmaceutical company …
President Donald Trump has signed a bill giving terminally ill patients the right to try experimental treatments not approved by the government. Patients were able …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
